Inhibition of Peroxidase Activity of Cytochrome c: De Novo Compound Discovery and Validation
Related Experiment Video
Updated: Apr 10, 2026

Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
Ahmet Bakan1, Alexandr A Kapralov1, Hulya Bayir1
1Department of Computational and Systems Biology, School of Medicine (A.B., F.H., I.B.), and Department of Environmental and Occupational Health (A.A.K., H.B., V.E.K.), University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract:
Cytochrome c (cyt c) release from mitochondria is accepted to be the point of no return for eliciting a cascade of interactions that lead to apoptosis. A strategy for containing sustained apoptosis is to reduce the mitochondrial permeability pore opening. Pore opening is enhanced by peroxidase activity of cyt c gained upon its complexation with cardiolipin in the presence of reactive oxygen species. Blocking access to the heme group has been proposed as an effective intervention method for reducing, if not eliminating, the peroxidase activity of cyt c. In the present study, using a combination of druggability simulations, pharmacophore modeling, virtual screening, and in vitro fluorescence measurements to probe peroxidase activity, we identified three repurposable drugs and seven compounds that are validated to effectively inhibit the peroxidase activity of cyt c.
Insights
Researchers identified drugs that inhibit cytochrome c peroxidase activity, a key step in apoptosis. This finding offers a new strategy to control programmed cell death by targeting mitochondrial permeability.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cytochrome c (cyt c) release from mitochondria triggers apoptosis.
- Mitochondrial permeability pore opening, enhanced by cyt c's peroxidase activity, is crucial for apoptosis.
- Inhibiting cyt c's peroxidase activity, particularly its heme group access, can control apoptosis.
Purpose of the Study:
- To identify compounds that inhibit the peroxidase activity of cytochrome c.
- To explore therapeutic strategies for controlling apoptosis by targeting cyt c.
Main Methods:
- Druggability simulations
- Pharmacophore modeling
- Virtual screening
- In vitro fluorescence measurements
Main Results:
- Identified three repurposable drugs that inhibit cyt c peroxidase activity.
- Identified seven novel compounds that inhibit cyt c peroxidase activity.
- Validated the compounds' efficacy in inhibiting peroxidase activity.
Conclusions:
- Blocking access to the heme group of cyt c is an effective strategy to reduce its peroxidase activity.
- The identified drugs and compounds show potential for therapeutic intervention in apoptosis-related conditions.
Related Concept Videos
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Enzyme Inhibition
Peroxisomes
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Inhibition of CDK Activity
Inhibition of Cdk Activity

